Lexaria Bioscience (LEXX) has been granted two new patents from the United States Patent and Trademark Office for the use of DehydraTECH ...

The volume of business method patents is staggering, and in part a function of the fact that business methods are only patentable in the United States. The volume is also partly a function of the ...

KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), a drug delivery platform innovator with a market capitalization of $29.84 million, has announced the issuance of two new patents by ...

Aclarion (ACON) has received a Notice of Allowance from the United States Patent and Trademark Office for its 24th issued US patent. Whereas ...

The United States Patent and Trademark Office recently issued patent 12,178,937 entitled “Compositions and Methods for ...

Certain products and/or services offered by Univision Communications Inc. and its subsidiaries (collectively, “Univision”), including but not limited to univision.com, Univision NOW, the ...

The legitimization of gene patents in the United States was an outgrowth of legal and political changes that were initiated in response to the economic dislocations of the late 1970s and early 1980s.

They are licensed to prepare and negotiate patent applications both in the United States and internationally, and may represent solo inventors, large corporations, or anything in between. Patent ...